2020, Número S4
<< Anterior Siguiente >>
Med Int Mex 2020; 36 (S4)
Lípidos en pacientes con COVID-19
Arenas-Moya D
Idioma: Español
Referencias bibliográficas: 17
Paginas: 21-23
Archivo PDF: 284.65 Kb.
FRAGMENTO
ANTECEDENTES
La morbilidad y mortalidad por COVID-19 se han relacionado con la
aparición de la tormenta de citocinas, con incremento de IL-6 e TNF-α,
sobre todo en el tejido pulmonar. Un régimen nutricional que incorpore
lípidos específicos pudiera modular la inflamación y ayudar en
la evolución clínica. Puesto que recién empieza a surgir información
vinculada con esta infección, las recomendaciones aquí propuestas,
relacionadas con la fisiopatología de este y otros virus similares, en
el síndrome de dificultad respiratoria aguda, se basan en evidencia
preclínica y observacional.
REFERENCIAS (EN ESTE ARTÍCULO)
Das UN. Can Bioactive Lipids Inactivate Coronavirus (COVID- 19)? Arch Med Res. 2020; 51 (1): 282-85. https://doi. org/10.1016/j.arcmed.2020.03.004
Lordan R, et al. Inflammation and cardiovascular disease: are marine phospholipids the answer? Food & function. 2020 (4). https://doi.org/10.1039/C9FO01742A
Messina G, et al. Functional role of dietary intervention to improve the outcome of COVID-19: A hypothesis of work. Int J Mol Sci. 2020; 21 (9): 3104. https://doi.org/10.3390/ ijms21093104
Zabetakis I, et al. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients 2020; 12 (5). https://doi.org/10.3390/nu12051466
Panigrahy D, et al. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? Cancer and Metastasis Reviews. 2020; 39: 337-40. https://doi. org/10.1007/s10555-020-09889-4
Wei X, et al. Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol. 2020; 14 (3): 297-304. https:// doi.org/10.1016/j.jacl.2020.04.008
Calder PC, et al. Optimal nutritional status for a wellfunctioning immune system is an important factor to protect against viral infections. Nutrients 2020; 12 (4): 1181. https://doi.org/10.3390/nu12041181
Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br J Clin Pharmacol. 2013; 75 (3). https://doi.org/10.1111/j.1365- 2125.2012.04374.x
Basil MC, Levy BD. Specialized pro-resolving mediators: Endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016; 16: 51. doi. 10.1038/nri.2015.4
Stark KD, et al. Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults. Progress in Lipid Research 2016; 63: 132-52. https://doi.org/10.1016/j.plipres.2016.05.001
Iddir M, et al. Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis. Nutrients 2020; 12 (1562). https://doi.org/10.3390/ nu12061562
Ghaffari S, et al. Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/ COVID-19. Arch Med Res. 2020; 51 (5): 464-67. https://doi. org/10.1016/j.arcmed.2020.04.006
Bousie E, et al. Relevance of non-nutritional calories in mechanically ventilated critically ill patients. Eur J Clin Nutr. 2016; 70: 1443-50. https://doi.org/10.1038/ejcn.2016.167
Martindale R, et al. Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care. Am Soc Parenter Enter Nutr. 2020; 44 (7). https://doi.org/10.1002/jpen.1930
Romano L, et al. Short Report – Medical nutrition therapy for critically ill patients with COVID-19. Eur Rev Med Pharmacol Sci. 2020; 24: 4035-39.
Barazzoni R, et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr. 2020; 39 (6): 1631-38. https://doi.org/10.1016/j.clnu.2020.03.022
Li C, et al. Enteral immunomodulatory diet (omega-3 fatty acid, γ-linolenic acid and antioxidant supplementation) for acute lung injury and acute respiratory distress syndrome: An updated systematic review and meta-analysis. Nutrients 2015; 7 (7): 5572-85. https://doi.org/10.3390/nu7075239